State Board of Administration of Florida Retirement System’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Sell
115,011
-13,678
-11% -$301K ﹤0.01% 986
2026
Q1
$2.86M Hold
128,689
0.01% 932
2025
Q4
$3.44M Hold
128,689
0.01% 887
2025
Q3
$2.75M Sell
128,689
-3,616
-3% -$85.5K ﹤0.01% 940
2025
Q2
$2.85M Buy
132,305
+97,724
+283% +$1.82M 0.01% 928
2025
Q1
$574K Hold
34,581
﹤0.01% 1421
2024
Q4
$635K Hold
34,581
﹤0.01% 1421
2024
Q3
$532K Hold
34,581
﹤0.01% 1519
2024
Q2
$562K Sell
34,581
-5,300
-13% -$85.5K ﹤0.01% 1467
2024
Q1
$751K Buy
39,881
+5,300
+15% +$131K ﹤0.01% 1312
2023
Q4
$1.08M Hold
34,581
﹤0.01% 1212
2023
Q3
$721K Buy
34,581
+180
+0.5% +$4.89K ﹤0.01% 1363
2023
Q2
$824K Sell
34,401
-5,480
-14% -$122K ﹤0.01% 1304
2023
Q1
$751K Hold
39,881
﹤0.01% 1360
2022
Q4
$635K Sell
39,881
-7,730
-16% -$121K ﹤0.01% 1462
2022
Q3
$779K Hold
47,611
﹤0.01% 1329
2022
Q2
$671K Hold
47,611
﹤0.01% 1478
2022
Q1
$1.15M Hold
47,611
﹤0.01% 1286
2021
Q4
$1.11M Hold
47,611
﹤0.01% 1379
2021
Q3
$791K Hold
47,611
﹤0.01% 1572
2021
Q2
$1.16M Sell
47,611
-72,829
-60% -$1.64M ﹤0.01% 1365
2021
Q1
$3.11M Sell
120,440
-6,550
-5% -$288K 0.01% 984
2020
Q4
$6.79M Sell
126,990
-3,368
-3% -$167K 0.01% 765
2020
Q3
$5.38M Buy
130,358
+830
+0.6% +$35.8K 0.01% 770
2020
Q2
$6.28M Buy
129,528
+74,305
+135% +$3.57M 0.02% 723
2020
Q1
$2.33M Hold
55,223
0.01% 888
2019
Q4
$2.36M Sell
55,223
-1,050
-2% -$45.7K 0.01% 1003
2019
Q3
$2.02M Sell
56,273
-4,054
-7% -$123K 0.01% 1036
2019
Q2
$1.61M Buy
60,327
+2,930
+5% +$74.8K ﹤0.01% 1145
2019
Q1
$1.54M Hold
57,397
﹤0.01% 1163
2018
Q4
$928K Hold
57,397
﹤0.01% 1375
2018
Q3
$1.19M Hold
57,397
﹤0.01% 1392
2018
Q2
$876K Sell
57,397
-75,330
-57% -$1.34M ﹤0.01% 1575
2018
Q1
$2.98M Sell
132,727
-900
-0.7% -$24.9K 0.01% 939
2017
Q4
$4.02M Buy
133,627
+1,540
+1% +$49.2K 0.01% 879
2017
Q3
$4.98M Hold
132,087
0.01% 815
2017
Q2
$3.68M Buy
132,087
+20,390
+18% +$608K 0.01% 891
2017
Q1
$3.84M Buy
111,697
+186
+0.2% +$6.57K 0.01% 863
2016
Q4
$3.22M Buy
111,511
+9,134
+9% +$242K 0.01% 902
2016
Q3
$3.26M Buy
102,377
+4,000
+4% +$136K 0.01% 896
2016
Q2
$3.19M Buy
98,377
+40,116
+69% +$1.34M 0.01% 900
2016
Q1
$1.63M Hold
58,261
0.01% 1132
2015
Q4
$2.08M Hold
58,261
0.01% 1039
2015
Q3
$1.93M Hold
58,261
0.01% 1075
2015
Q2
$2.44M Buy
58,261
+738
+1% +$28.6K 0.01% 1035
2015
Q1
$1.88M Buy
57,523
+2,466
+4% +$84.8K 0.01% 1174
2014
Q4
$1.75M Buy
55,057
+500
+0.9% +$14.2K 0.01% 1208
2014
Q3
$1.35M Hold
54,557
﹤0.01% 1333
2014
Q2
$1.23M Buy
54,557
+20,131
+58% +$420K ﹤0.01% 1480
2014
Q1
$838K Buy
34,426
+9,070
+36% +$229K ﹤0.01% 1703
2013
Q4
$634K Hold
25,356
﹤0.01% 1888
2013
Q3
$697K Hold
25,356
﹤0.01% 1816
2013
Q2
$460K Buy
+25,356
New +$349K ﹤0.01% 2028

Other funds holding ACAD

State Board of Administration of Florida Retirement System's ACAD Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System reduced its Acadia Pharmaceuticals (ACAD) stake by 11% in Q2 2026, selling an estimated $301K and leaving 115,011 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #986.

State Board of Administration of Florida Retirement System first reported a position in ACAD in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.79M in Q4 2020. 175 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 115,011 shares of Acadia Pharmaceuticals worth $2.91M as of Q2 2026.
  • State Board of Administration of Florida Retirement System sold 13,678 Acadia Pharmaceuticals shares in Q2 2026, an estimated $301K.
  • Acadia Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #986 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • State Board of Administration of Florida Retirement System's Acadia Pharmaceuticals position peaked at $6.79M in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.